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AbstrAct
A mutation in the HERC2 gene has been linked to a severe neurodevelopmental 
disorder with similarities to the Angelman syndrome. This gene codifies a protein 
with ubiquitin ligase activity that regulates the activity of tumor protein p53 and is 
involved in important cellular processes such as DNA repair, cell cycle, cancer, and iron 
metabolism. Despite the critical role of HERC2 in these physiological and pathological 
processes, little is known about its relevance in vivo. Here, we described a mouse with 
targeted inactivation of the Herc2 gene. Homozygous mice were not viable. Distinct 
from other ubiquitin ligases that interact with p53, such as MDM2 or MDM4, p53 
depletion did not rescue the lethality of homozygous mice. The HERC2 protein levels 
were reduced by approximately one-half in heterozygous mice. Consequently, HERC2 
activities, including ubiquitin ligase and stimulation of p53 activity, were lower in 
heterozygous mice. A decrease in HERC2 activities was also observed in human skin 
fibroblasts from individuals with an Angelman-like syndrome that express an unstable 
mutant protein of HERC2. Behavioural analysis of heterozygous mice identified an 
impaired motor synchronization with normal neuromuscular function. This effect was 
not observed in p53 knockout mice, indicating that a mechanism independent of 
p53 activity is involved. Morphological analysis showed the presence of HERC2 in 
Purkinje cells and a specific loss of these neurons in the cerebella of heterozygous 
mice. In these animals, an increase of autophagosomes and lysosomes was observed. 
Our findings establish a crucial role of HERC2 in embryonic development and motor 
coordination.
                   Research Paper: Pathology
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INtrODUctION
Angelman syndrome (AS) is a severe 
neurodevelopmental disorder that occurs in approximately 
one out of every 12,000 births. Patients with AS exhibit 
developmental delay, speech impairments, intellectual 
disability, epilepsy, abnormal electroencephalograms, 
puppet-like ataxic movements, prognathism, tongue 
protrusion, paroxysms of laughter, abnormal sleep 
patterns, hyperactivity, and a high prevalence of autism 
[1, 2]. Genetic studies revealed that AS is associated with 
maternal deletions of chromosome 15q11-q13, paternal 
chromosome 15 uniparental disomy, or rare imprinting 
defects that affect the transcription of genes within the 
15q11-q13 region. Specific loss-of-function mutations in 
the maternally inherited UBE3A gene which resides within 
this chromosomal region have been identified in a subset 
of affected individuals [3]. The UBE3A gene encodes an 
E3 ubiquitin ligase called UBE3A or E6-associated protein 
(E6AP). More recently, a mutation in the HERC2 gene has 
been linked to neurodevelopmental delay and dysfunction 
in both AS and autism-spectrum disorders among the 
Old Order Amish [4, 5]. Molecular analysis associated 
a missense mutation in the HERC2 gene (c.1781C>T, 
p.Pro594Leu) with the disease phenotype. Although the 
HERC2 gene also resides in the 15q11-q13 region, it seems 
that it is not imprinted [6]. HERC2 encodes an ubiquitin 
ligase that binds to UBE3A and stimulates its ubiquitin 
ligase activity [7]. Deregulation of the activity of UBE3A 
is well recognized as contributing to the development of 
AS [2, 3]. Thus, disruption of HERC2 function by this 
mutation is associated with a reduction in UBE3A activity 
resulting in neurodevelopmental delay with Angelman-like 
features [4, 5].
Genetic variations in the HERC2 gene are associated 
with eye pigmentation. Although multiple genes contribute 
to eye colour in humans, most variation can be attributed 
to a strong interaction between HERC2 and adjacent 
OCA2 on chromosome 15 [8]. A distal regulatory element 
of the OCA2 promoter is within intron 86 of the HERC2 
gene and three different sequence variants of HERC2 have 
been identified, such as predictors of eye colour in humans 
[9, 10].
HERC2 belongs to the HERC gene family that 
encodes a group of proteins that contain multiple structural 
domains. All members have at least one copy of an 
N-terminal region showing homology to the cell cycle 
regulator RCC1 and a C-terminal HECT (homologous to 
the E6-AP carboxyl terminus) domain found in a number 
of E3 ubiquitin protein ligases. These two domains define 
the HERC family (HERC = HECT + RCC1) [11]. In 
humans, six members form the HERC family. They are 
classified into two groups: large (HERC1-2) and small 
(HERC3-6) proteins. Structurally, small HERC proteins 
contain the two characteristic domains HECT and 
RCC1, whereas large HERC proteins are giant proteins 
(approximately 5,000 amino acid residues) containing 
additional domains, including several RCC1 domains. 
Functionally, the HERC protein family regulates 
ubiquitination and ISGylation processes associated with 
membrane trafficking, immune response, DNA repair, 
cell stress response and cancer biology [11-20]. Recently, 
several substrates of HERC2 have been identified. HERC2 
targets ubiquitin-dependent proteasomal degradation to 
xeroderma pigmentosa A (XPA) during circadian control 
of nucleotide excision repair [21] and the breast cancer 
suppressor BRCA1 during the cell cycle [22]. These data, 
together with the interaction of HERC2 with RNF8 [23], 
indicate a regulatory role for HERC2 in DNA repair by 
nucleotide excision and by homologous recombination 
of DNA double-strand breakage. More recently, other 
substrates, such as NEURL4, USP33 or FBXL5, have 
been reported that also indicate the participation of 
HERC2 in other important cellular processes such as 
centrosome architecture, β-adrenergic receptor recycling, 
RalB signaling, cancer cell migration, and iron metabolism 
[24-26].
HERC2 may also interact with proteins in a manner 
independent of proteasomal degradation. The tumor 
suppressor p53 is a transcription factor that coordinates 
the cellular response to several kinds of stress through the 
regulation of a wide range of genes [27, 28]. In response 
to stress, p53 transcriptional activation is dependent of 
its oligomerization state [29]. Thus, p53 mutations that 
impair its oligomerization have been associated with 
a rare hereditary cancer predisposition disorder called 
Li-Fraumeni syndrome [30, 31]. HERC2 interacts 
with p53 and modulates its transcriptional activity by 
regulating its oligomerization [32]. RNA interference 
experiments showed that HERC2 knock-down inhibited 
p53 oligomerization affecting its transcriptional activity. 
Under these conditions, up-regulation of cell growth and 
increased focus formation were observed, suggesting 
an important role of HERC2 in proliferation [32]. In 
agreement with these observations, an association of 
frameshift mutations of HERC2 with gastric and colorectal 
carcinoma has been described [18]. Despite the critical 
role of HERC2 in cellular processes regulated by p53, 
little is known about its physiological relevance. The 
mutation of HERC2 found among the Old Order Amish 
with features similar to Angelman syndrome also suggests 
an important role for HERC2 in neurodevelopment [4, 5]. 
To determine the physiological importance of HERC2, we 
decided to generate a mouse with targeted inactivation of 
the Herc2 gene. 
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rEsULts
characterization of the Herc2530 mice
To study the physiological role of HERC2, we 
generated a novel mutant allele at the Herc2 locus by 
using a gene trapped embryonic stem (ES) cell line from 
The Sanger Institute. These ES cells, here called Herc2530, 
contain a pGT0lxr expression vector with a strong splice 
acceptor site integrated within intron 2 of the mouse 
Herc2 gene, which results in the expression of a truncated 
mRNA. PCR experiments with genomic DNA from the 
tails of mice generated with these ES cells confirmed the 
integration of the trap between exon 2 and 3 (Figure 1A). 
Figure 1: Generation of the Herc2530 mice. A. Schematic representation of the Herc2 wild-type allele (Herc2+) and Herc2530 
allele and the designed primers to identify both alleles (left). The Herc2530 allele contains the pGT0lxr vector that expresses the fusion of 
β-galactosidase and neomycin transferase within intron 2. The integration of the trap was determined by genotyping using the indicated 
primers (right), 530KO01/530KO04 for the wild-type allele and Gal7/Gal8 for the 530 allele. b. Exon structure of Herc2+ and Herc2530 
(left). RT-PCR experiments with mRNA from liver, spleen and kidney of Herc2+ and Herc2530 mice was performed using the indicated 
primers. c. PCR products from B were sequenced. The trap was inserted after exon 2, for which the mutant protein contains the first 24 
amino acids of the HERC2 and β-galactosidase protein. D. β-galactosidase expression in Herc2530 mice. The activity of β-galactosidase was 
determined in the testes, brain, heart and kidney of Herc2530 mice and detected by X-gal staining. E. Scheme of HERC2 protein and the 
expected product from the Herc2530 allele. The P594L pathological mutation is indicated (*). RLD: RCC1-like domain.
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RT-PCR experiments with mRNA from different tissues 
showed the formation of a truncated mRNA of Herc2 
fused to β-galactosidase (β-geo) (Figure 1B). Sequencing 
analysis confirmed these results and revealed the fusion 
of β-galactosidase after amino acid residue 24 of HERC2 
(Figure 1C). β-galactosidase activity was determined in 
several tissues (Figure 1D), confirming the expression of 
a fused transcript of the first 24 amino acid residues of 
HERC2 with β-galactosidase. Because mouse HERC2 
protein has 4,836 amino acid residues, we can consider 
that the HERC2 new mutant allele Herc2530 is functionally 
deleted (Figure 1E).
Herc2 is an essential gene during embryonic 
development
91 offspring born from the intercross heterozygous 
mice were genotyped by PCR. Among these mice, 34 
(37%) were wild-type for Herc2, and 57 (63%) were 
heterozygous for Herc2+/530 (Figure 2A). We could not 
Figure 2: Analysis of progeny from the Herc2+/530 cross. A. Analysis of offspring born from the intercross of Herc2+/530 mice. 
Ninety-one animals were genotyped by PCR of genomic DNA isolated from mouse tails. The expected frequencies for Herc2+/+ and 
Herc2+/530 were obtained; however, no homozygous mice (Herc2530/530) were identified. b. Analysis of embryonic lethality in Herc2530/530 
mice. Embryos from Herc2+/530 pregnant females at different stages were isolated and genotyped. The Herc2+/+ and Herc2+/530 genotypes 
were identified, but not the Herc2530/530. The placentas without embryos could not be genotyped. c. Analysis of HERC2 protein levels during 
development. Lysates from brains at different stages were analyzed by immunoblotting for HERC2 and β-actin. E16 (embryonic day), P0, 
P5 and P15 (post-natal day 0, 5 and 15, respectively) and AD (adult animal). 
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identify any viable homozygous Herc2530/530. These 
data suggested an embryonic lethality for null mice. To 
determine the time of embryonic lethality in Herc2530/530 
mice, genomic DNA was isolated from embryos 
harvested at different stages (E7.5, E8.5 and E10.5) of 
pregnancy from Herc2+/530 mice. We isolated 34 placentas 
and observed 14 (41%) without embryos (Figure 2B). 
Among the embryos, we identified both wild-type and 
heterozygous mice, but not homozygous mice. At day 7.5 
and 8.5 in placentas without embryos, we observed some 
residuals. At day 10.5, these residuals were completely 
resorbed. Most likely, these residuals were rests of 
embryos homozygous for Herc2530. These results indicate 
that the expression of at least a normal Herc2 copy is 
essential for the completion of embryonic development 
before day 7.5. 
Genes important for development are usually 
highly expressed during embryonic stages. To determine 
the expression pattern of the HERC2 protein during 
development, we analyzed the levels of the endogenous 
protein in samples from brains at embryonic day E16, 
postnatal days P1, P5 and P15, and adult mice (8 weeks). 
Anti-HERC2 antibodies detected a double band that 
decreased during development, with the highest levels in 
the embryonic stage and lower levels in the adult animal 
(Figure 2C). Similar expression profiles were observed for 
other members of the HERC family, such as HERC1 or 
HERC3 (data not shown), suggesting an important role of 
the HERC proteins during embryonic development. 
p53 inactivation did not rescue embryonic 
lethality of homozygous Herc2530 mice
Growth curves and survival rates were analyzed in 
Herc2+/530 mice. The growth curve was not significantly 
altered in Herc2+/530 mice during the time studied (Figure 
3A). The survival rate was also similar to wild-type mice 
during the period studied (Figure 3B).
Figure 3: p53 inactivation did not rescue the lethality of Herc2530/530 homozygous mice. Graphs of growth rate A. and survival 
b. from Herc2+/+ and Herc2+/530 mice. Growth and survival were analyzed in male mice (n>10) at the indicated weeks. The survival for 
p53-/- mice also was analyzed. c. The analysis of mice from a cross of double heterozygous Herc2+/530 p53+/- animals. The offspring was 
genotyped by PCR of genomic DNA with the appropriate primers, indicating that the embryonic lethal phenotype of Herc2530/530 embryos 
was not rescued by crossing with p53-/- mice. 
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Figure 4: Herc2+/530 mice show reduced levels of HErc2 protein. A. HERC2 protein levels were analyzed by immunoblotting 
using specific antibodies against HERC2 in several tissues from 8 week old mice. The levels of HERC2 were quantified (n = 8) and 
normalized with respect to β-actin levels. b. β-galactosidase expression in brain from Herc2530 mouse. The β-galactosidase activity was 
detected ubiquitously in all areas using X-gal staining. However, there were forebrain cortical and subcortical areas in which β-galactosidase 
labeling was the most intense (asterisks). c. The levels of HERC2 were analyzed by immunoblotting in lysates of cerebellum, cerebral 
cortex and diencephalon from Herc2+/+ and Herc2+/530 mice at P4 (post-natal day 4). BA, basal amygdala. CA1, pyramidal cell layer 
of the hippocampal cornu ammonis 1. DEn, dorsal endopiriform nucleus. DG, granular cell layer of hippocampal dentate gyrus. DM, 
dorsomedial nucleus of the hypothalamus. Pir, piriform cortex. PV, paraventricular thalamic nucleus. RSG, retrosplenial granular cortex. 
VM, ventromedial nucleus of the hypothalamus.
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It had been previously demonstrated that knockout 
mice for the E3 ubiquitin ligases of p53, such as MDM2 
or MDM4, are lethal in embryonic stages due to growth 
inhibition and apoptosis. Interestingly, this lethality could 
be rescued by concomitant p53 depletion [33-35]. Because 
HERC2 is an E3 ubiquitin ligase that regulates p53 activity 
[32], we asked whether p53 inactivation might also rescue 
the lethality of Herc2530/530 homozygous mice. We crossed 
double heterozygous Herc2 and p53 mice (Herc2+/530 p53+/- 
mice) to obtain double homozygous mice. We analyzed 
the genotype of the offspring by performing an adequate 
PCR assay on of genomic DNA samples but did not 
observe any viable Herc2530/530 mouse (Figure 3C). These 
data suggest the non-involvement of p53 in the embryonic 
death caused by the depletion of Herc2. 
Partial inactivation of the Herc2 gene is sufficient 
to reduce HErc2 protein levels and activity 
We analyzed protein levels of HERC2 in Herc2+/530 
animals by immunoblotting. We observed that the levels 
of HERC2 were decreased approximately 50% in the brain 
and kidney of Herc2+/530 animals (Figure 4A). The analysis 
of β-galactosidase activity in Herc2+/530 mice allows the 
analysis of Herc2 expression in more detail. Ubiquitous 
expression of HERC2 was observed in all tissues analyzed 
(Figure 1D). In the brain, this expression was higher in 
the hippocampus (pyramidal cell layer and granular layer 
of dentate gyrus), hypothalamic nucleus (dorsomedial and 
ventromedial), amygdaloid nucleus (basal and medial), 
piriform cortex, dorsal endopiriform nucleus, entorhinal 
cortex, retrospenial cortex, paraventricular thalamic 
nucleus, and cerebellum (Figure 4B and data not shown). 
Figure 5: Herc2+/530 mice show reduced activity of HErc2. A. USP33, a substrate of ubiquitination of HERC2, was analyzed in 
lysates (cerebellum, cerebral cortex and diencephalon) from 8 week old mice by immunoblotting. Higher levels of USP33 were observed 
in all areas of Herc2+/530 mice. Levels of USP33 were quantified and normalized with respect to β-actin levels. b. Herc2+/530 mice show 
reduced levels of p21 mRNA. RT quantitative PCR analyses were performed in forebrain and cerebellum from Herc2+/+ and Herc2+/530 mice 
to quantify p21 gene expression (n = 10). The levels of expression were normalized with respect to GAPDH gene expression. 
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These observations were confirmed by immunoblotting. 
We dissected the cerebellum, cerebral cortex and 
diencephalon, detecting HERC2 protein in all these areas 
(Figure 4C). The levels of HERC2 protein were reduced 
in Herc2+/530 animals (Figure 4C) with respect to control 
mice (Herc2+/+).
These data show that the levels of HERC2 protein 
are reduced almost 50% in Herc2+/530 mice tissues and 
suggest that the HERC2 activity must also decrease in the 
brain of heterozygous animals. Two activities have been 
associated with HERC2 protein; an E3 ubiquitin ligase 
activity which regulates protein levels of USP33, BRCA1 
or XPA [21, 22, 25], and an activity as a stimulator of 
the p53 oligomerization that regulates the transcriptional 
activity of p53 [32]. To analyze the activity of E3 ubiquitin 
ligase, we performed immunoblotting experiments in 
the mouse brain areas with antibodies against substrates 
ubiquitinated by HERC2. Only the USP33 protein was 
detected by immunoblotting in these mouse samples 
(Figure 5A). Interestingly, in Herc2+/530 mice, the 
levels of USP33 were higher than in control mice. To 
examine the activity stimulating p53 oligomerization and 
transcriptional activity, we analyzed the levels of p21 
mRNA by RT quantitative PCR analysis. A decrease in p21 
mRNA levels was observed in Herc2+/530 mice (Figure 5B). 
Altogether, these data show that the partial inactivation of 
the Herc2 gene in Herc2+/530 mice is sufficient to reduce 
HERC2 protein levels and activity.
A homozygous mutation in human Herc2 causes 
an Angelman-like syndrome and reduces the 
activity of the HErc2 protein
HERC2 has been implicated in a human disorder 
with some features similar to Angelman syndrome. The 
substitution of proline by leucine at amino acid position 
594 in HERC2 caused HERC2P594L instability and almost 
total loss of the protein in homozygosis [4, 5]. Based on 
our data from heterozygous animals, we hypothesized 
that these patients would have lower levels of HERC2 
activity. To test this hypothesis, we analyzed the levels 
of USP33 protein from fibroblasts derived from an 
affected individual and a healthy control. We observed 
a high increase of USP33 levels in fibroblasts from a 
patient (Figure 6A). To confirm that HERC2 activity was 
diminished, we also analyzed the levels of p21 protein. 
We observed a decrease in the p21 protein levels in 
fibroblasts from this patient (Figure 6A). However, the 
p53 and α-tubulin levels did not significantly change. 
The p21 mRNA levels also confirmed the decrease in 
p53 transcriptional activity in fibroblasts from the patient 
(Figure 6B). The level of p53 protein is regulated by the 
proteasome. In the presence of the proteasome inhibitor 
MG132, we observed a similar stabilization of p53 protein 
levels in fibroblasts from the patient and the control 
(Figure 6C). Under these conditions, we also detected 
a decrease in p21 protein levels in fibroblasts from the 
patient (Figure 6C), indicating a decrease in its p53 
activity. These data show the low activity of HERC2 in 
individuals carrying the HERC2P594L mutation. 
In conclusion, the low HERC2 activity found in 
Herc2+/530 mice (Figure 5) and in individuals with the 
HERC2P594L mutation (Figure 6A-6C) correlated with an 
increase in levels of the USP33 protein and a decrease 
in levels of the p21 protein. These data suggest that 
in conditions with low levels of HERC2 protein, cells 
could contain more USP33 and less p21. To confirm this 
point, human U2OS cells were depleted of HERC2 using 
interference RNA, and USP33 and p21 were analyzed 
by immunoblotting (Figure 6D). HERC2 knockdown 
increased levels of the USP33 protein and decreased levels 
of the p21 protein.
table 1: behavioural tests of Herc2+/530 mice 
cognitive task behavioural tests test Values: mean ± error (n) P valueHerc2+/+ Herc2+/530
Anxiety
Time outside of the dark box (s) 235 ± 13 (9) 232 ± 9 (8)  0.83
Immobile time suspended by the 






STM 0.24 ± 0.08 (6) 0.23 ± 0.05 (10) 0.87





STM 2.92 ± 0.24 (6) 2.21 ± 0.37 (15) 0.12
LTM 2.84 ± 0.31 (7) 3.04 ± 0.32 (19) 0.66
Motor function
Open field (total activity) 1649 ± 108 (8) 1612 ± 199 (16) 0.87
Rotarod (#Falls) 1.14 ± 0.46 (7) 4.21 ± 0.90 (19) **0.0058
Forelimb Grip strength (s) 7.00 ± 0.98 (6) 7.96 ± 0.78 (8) 0.46
STM: Short Term Memory; LTM: Long Term Memory; DI: Discrimination index; n: number of animals
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Figure 6: A homozygous mutation in human HERC2 that causes an Angelman-like syndrome reduces the activity of 
the HErc2 protein. A. Fibroblasts derived from individuals with HERC2 wild-type or HERC2 with the mutation P594L were analyzed 
by immunoblotting for the indicated antibodies. Levels of USP33 and p21 proteins were quantified and normalized with respect to α-tubulin 
levels. b. Levels of p21 mRNA were analyzed by RT quantitative PCR analysis and normalized with respect to 18S gene expression. c. 
The levels of HERC2, p53, p21 and α-tubulin proteins were analyzed in the presence or absence of the proteasome inhibitor MG132. D. 
U2OS cells were transfected with non-targeting (NT) or HERC2 siRNAs and analyzed by immunoblotting against the indicated proteins. 
The levels of USP33 or p21 were quantified and normalized with respect to Ran levels. 
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HErc2 regulates motor coordination
Individuals carrying the HERC2P594L mutation 
present a severe developmental delay with an unstable 
gait [4,5]. We wondered whether Herc2+/530 mice with 
a reduction of approximately 50% in HERC2 protein 
could have some features found in HERC2P594L patients. 
To examine this question, behavioural tests to measure 
different cognitive tasks were performed in Herc2+/530 and 
wild-type mice. Except for the rotarod test, no significant 
Figure 7: Impaired motor coordination in Herc2+/530 mice. A.-b. The number of falls from the rotarod increases in Herc2+/530 
mice at 6 months of age in comparison with control littermates. c. No difference was found in p53+/- and p53-/- mice in comparison with 
WT. (D-E) EMG measurements of CMAP amplitudes in the MG of control and Herc2+/530 mice show normal neurotransmission efficacy 
in postnatal heterozygous mice. D. Representative recordings during a train of stimuli at 100 Hz in a control and a Herc2+/530mouse. E. 
Depression of CMAP amplitudes (normalized to the first response) during a train of stimuli of 300 ms at 100 Hz in control (n = 7) and 
heterozygous mice (n = 18). The train index F., corresponding to the depression at the end of the train, and PPF (Pair -Pulse Facilitation) 
G., are similar between groups.
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differences between the two groups were found (Table 
1; Supplementary Video). Herc2+/530 mice displayed a 
statistically significant increase in rotarod falls compared 
to wild-type mice (Herc2+/+: 1.14 ± 0.46, n = 7 and 
Herc2+/530: 4.21 ± 0.90, n = 19, p = 0.0058) (Figure 7A-
7B), suggesting a role for HERC2 in motor coordination. 
Because HERC2 regulates p53 activity, we asked whether 
p53 inactivation could produce effects similar to Herc2+/530 
mice. We performed the rotarod test in p53+/- and p53-/- 
mice. No significant differences were observed compared 
to wild-type mice (Figure 7C). These data indicate that the 
impaired motor coordination in Herc2+/530 mice is specific 
and independent of p53. Next, we analyzed whether 
muscular function was affected in Herc2+/530 mice. The 
electrical neuromuscular properties of the Herc2+/530 mice 
were studied in vivo by performing electromyography 
(EMG) on the medial gastrocnemius (MG) muscle using 
short train stimuli at 100 Hz (Figure 7D). The depression 
at the end and the facilitation at the beginning of a train of 
30 stimuli were similar in mutant and wild-type mice when 
measured by normalization of the CMAP (Compound 
Muscular Action Potentials) amplitude (p = 0.8 and p = 
0.85, respectively) (Figure 7E-7G). These results indicate 
a normal muscular function. 
The cerebellum regulates motor coordination, 
and alterations in its structure have been associated 
with impaired motor coordination. To examine whether 
the deficit of motor synchronization in Herc2+/530 mice 
was caused by an alteration of cerebellar structure, 
we performed immunohistochemistry analysis of the 
specific marker of Purkinje cells calbindin-D28 k 
(CaBP) (Figure 8). CaBP immunoreactive Purkinje cell 
somata form a continuous cell layer in the cerebellar 
cortex of Herc2+/+ mice (Figure 8A-8C). In Herc2+/530 
mice, parasagittal zones devoid of immunoreactivity 
throughout the cerebellum indicative of Purkinje cell 
loss were observed (arrows and arrowheads in Figure 
8D-8F). These symmetrical Purkinje cell-deprived bands 
-characterized by the presence of wide spaces lacking 
cell somata in the Purkinje cells layer (asterisks in Figure 
8H) and dendritic debris through the molecular layer 
(mol in Figure 8H)-, were distributed differently along a 
medio-lateral gradient (see comparison between Figure 
8D-8F from a Herc2+/530 mouse and Figure 8A-8C from 
a Herc2+/+ mouse). Thus, vermal and paravermal Purkinje 
cells were less affected than in the cerebellar hemispheres. 
In the vermis and paravermis, the loss of Purkinje cells 
was distributed in narrow gaps (arrows in Figure 8D and 
8E), while at the hemispheres, the areas of Purkinje cells 
loss reached a great extension (arrowheads in Figure 8D 
and 8F), in which remain some surviving Purkinje cells 
(small arrows in Figure 8F). Epifluorescence microscopy 
analysis showed that HERC2 immunoreactivy in Purkinje 
cells colocalize with CaBP (Figure 9). In Herc2+/530 mice, 
HERC2 immunohistochemistry confirmed the loss of 
Purkinje cells in narrow gaps at the vermis/paravermis or 
in a greater extension at the hemispheres (Figure 9C-9E).
CaBP immunohistochemistry also revealed the 
presence of pathological signs in Herc2+/530 Purkinje 
cells. Rounded thickenings resembling axonal torpedoes 
were observed in Purkinje cell axons, which contrast with 
the fine grained morphology of normal Purkinje cells 
axonal plexuses (see arrows in the comparison between 
Herc2+/+ and Herc2+/530 in Figure 10A-10C). Phenotypic 
alterations of Herc2+/530 Purkinje cells were also observed 
in the 1.5 µm thick sections stained with toluidine blue 
(Figure 10D-10E). Disappeared Purkinje cells somata 
were substituted by glial Golgi-epithelial cells (Figure 
10D: arrows, Purkinje cells; small arrows, Golgi-epithelial 
cells). High magnification allowed to detect degenerative 
dark accumulations within the cytoplasm of the soma 
(arrowheads in Figure 10E) and the dendrites (arrows in 
Figure 10E) of the Purkinje cells. Electron microscopy 
analysis of cerebella confirmed these degenerative signs in 
Herc2+/530 mice (Figure 10F-10H and 11). The cytoplasm 
of Herc2+/530 Purkinje cells contained a high number of 
lysosomes and electron-dense debris (Figure 10F-10H, 
asterisks), and autophagosomes with different degrees 
of evolution (Figure 10G, arrows). Damaged cisterns 
of Golgi apparatus and numerous cisterns of the rough 
endoplasmic reticulum fused to the cytoplasmic face of 
the nuclear membrane were also observed (not shown). 
The difference between mice Herc2+/+ and Herc2+/530 was 
even most evident in the principal Purkinje cell dendrites 
(Pcd in Figure 11). Thus, numerous degenerative signs 
were present in Herc2+/530 Purkinje cells dendrite (Figure 
11B and 11E), while were almost absent in wild-type 
ones (Figure 11A, 11C and 11D). These degenerative 
signs were found in 2 and 9 month-old animals (Figure 
10F-10H), with a slight increase of these alterations in the 
older mice (not shown). These data show that the partial 
inactivation of HERC2 in Herc2+/530 mice causes Purkinje 
cell loss, which explain motor incoordination detected 
here in rotarod test. The increase of autophagosomes and 
lysosomes observed in Herc2+/530 Purkinje cells (Figure 
10 and 11) led us to wonder whether HERC2 may be 
involved in the regulation of autophagy. To this end, 
we have analyzed the adaptor-substrate p62/SQSTM1 
by laser confocal microscopy. HERC2 immunostaining 
colocalized with p62 (Figure 12). This colocalization, it 
was observed both in wild-type animals as in Herc2+/530 
animals (Figure 12, arrows and arrowheads in the merged). 
In Herc+/+ mice, p62 immunostaining showed a punctate 
labeling pattern that concentrated in Purkinje cells somata 
(Figure 12, arrows). This pattern was altered in Herc2+/530 
animals; thus, in addition to the somatic labeling, p62 
immunostaining was also evident within the dendritic 
trees and the axonal torpedoes of Purkinje cells (Figure 
12, arrows and arrowheads) indicating a dysregulation 
of autophagy in Herc2+/530 Purkinje cells. Altogether, 
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Figure 8: Purkinje cells loss in Herc2+/530 mice. Microphotographs of coronal sections through the cerebellar cortex of 9 months old 
wild-type (wt, A-c, G) and 9 months old Herc2+/530 mice (+/530, D-F, H). Calbindin immunohistochemistry shows as Purkinje cell somata 
form a continuous cell layer in the Herc2+/+ (wt) cerebellum  (A-C) However, parasagittal zones lacking of immunoreactivity throughout 
the Herc2+/530 cerebellum indicative of Purkinje cell loss are observed (arrows and arrowheads, in (D-F). These symmetrical Purkinje cells 
deprived bands, characterized by the presence of wide spaces lacking Purkinje cell somata (H, asterisks) and dendritic debris through the 
molecular layer (H, mol), distribute differently according a medio-lateral gradient. In the vermis and paravermal zones the immunonegative 
zones are sagittaly distributed in narrow gaps (D-E, arrows); while at the hemispheres the areas devoid of Purkinje cells, also bilateral, 
reach a greater extension (D, F, arrowheads) in which remain some surviving Purkinje cells (F, small arrows). G, illustrates the Herc2+/+ 
(wt) immunostaining of normal Purkinje cells; note as dendritic trees fulfill the molecular layer (G, mol), while Purkinje cells somata align 
in a continuous row. PCl, Purkinje cells layer. Bars = 600 µm (A, D), 400 µm (B-C, E-F), and 30 µm  (G-H).
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Figure 9: HErc2 is present in Purkinje cells. Microphotographs of coronal sections through the cerebellar cortex of 9 months old 
Herc2+/+ (wt, A.-b.) and 9 months old Herc2+/530 mice (+/530, D.-E.). Epifluorescence microscopy analysis shows that HERC2 is expressed 
in all the adult Purkinje cells colocalizating with the general marker of Purkinje cell calbindin (CaBP) (A-E) in the cerebellar cortex (A, 
Cc,), and their axonal endings in the cerebellar nuclei (A, Cn, arrow). Herc2+/530 cerebellum displays parasagittal bands of Purkinje cells 
loss in the vermis and paravermal zones (c., arrows; D, arrowheads), and areas of extensive Purkinje cell loss in the cerebellar paraflocculus 
(asterisks). The arrows in E illustrate the co-expression of both proteins in the Purkinje cell dendritic tree. Bars = 750µm (C), 200 µm (A), 
100µm (D), 75µm (E), and 50 µm (B).
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Figure 10: Purkinje cell degeneration in Herc2+/530 mice. Microphotographs of transmitted light A.-E. and electron microscopy 
F.-H. of parasagittal sections through the cerebellar cortex of 9 months Herc2+/+ (wt, A), and 2 (H) and 9 months old Herc2+/530 mice 
(+/530, b.-G.). Calbindin immunohistochemistry reveals the presence of rounded thickenings resembling to axonal torpedoes in Herc2+/530 
Purkinje cell axons (B-C, arrows), which contrast with the fine grained morphology of normal Purkinje cells axonal plexuses (A, arrows). 
1.5 µm thick sections illustrated Purkinje cells (D, arrows) limiting a zone in which disappeared Purkinje cells were substituted by glial 
Golgi-epithelial cells (small arrows in D and E). High magnification allows detect degenerative dark accumulations within the cytoplasm 
of the soma (E, arrowhead) and the dendrites (E, arrows) of the Purkinje cells. Herc2+/530 Purkinje cells cytoplasm possesses lysosomes, 
electron-dense debris (F-H, asterisks), and autophagosomes with different degrees of evolution (G, arrows). Pcn, Purkinje cell nucleus. Bars 
= 50 µm (A-D), 25 µm (E), and 1 µm (F-H).
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Figure 11: Ultrastructural analysis of Herc2+/530 mice indicates accumulation of autophagosomes and lysosomes in 
Purkinje cells. Electron photomicrographs of parasagittal sections through the cerebellar vermis of 9 months old Herc2+/+ (wt, A., c.-
D.) and 9 months old Herc2+/530 mice (+/530, b., E.). An important difference in the presence of autophagic (arrowheads), and lysosomal 
(arrows) organelles can be observed between wild-type (A) and Herc2+/530 (B) Purkinje cells cytoplasm. The difference is even most evident 
in the principal Purkinje cell dendrites. Thus, numerous degenerative signs are present in Herc2+/530 Purkinje cells dendrite (E), while are 
almost absent in wild-type ones (C-D). Pcd, Purkinje cell dendrite. Pcn, Purkinje cell nucleus. Bars = 2 µm (A-C, E), and 1 µm (D).
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these findings suggest that HERC2 plays an active role 
in regulating the Purkinje cells homeostasis, whose 
deregulation elicits alterations in motor coordination. 
DIscUssION
We have generated a new mutant allele of the 
HERC2 ubiquitin ligase, Herc2530, which has led us 
to identify Herc2 as an essential gene for embryonic 
development. The HERC2 gene encodes an unusual long 
polypeptide chain of almost 5,000 amino acid residues. 
The maintenance during evolution of this single and long 
polypeptide chain suggests an important physiological role 
for the giant HERC2 protein. Here, we showed that the 
inactivation of Herc2 causes embryonic lethality before 
7.5 days. At that time, we observed a high number of 
abnormal placentas, probably indicating resorption of 
unviable embryos. Although we have not studied the cause 
of this embryonic lethality, a possibility could be defective 
implantation. The unviability of embryos when HERC2 is 
inactivated would be indicative of the difficulty of finding 
human individuals homozygous for mutations of this gene. 
To our knowledge, only the HERC2P594L mutation found 
in the Amish community has been reported in humans 
[45]. In these individuals, the HERC2 protein is unstable 
and low levels are detected, although apparently high 
enough to avoid embryonic lethality. Ubiquitin ligases 
that interact with p53, such as MDM2 or MDM4, had also 
been identified as essential during embryonic phases. The 
absence of MDM2 induces embryonic lethality in mice 
at the peri-implantation (E4-E5.5) stage of development, 
whereas mice deficient for MDM4 die in mid-gestation 
(E7.5-E8.5) [33-35]. The lethality during these phases was 
rescued by a double knockout of the ubiquitin ligase and 
p53 [33-35]. Because HERC2 is also an ubiquitin ligase 
that interacts and regulates p53 activity [32], we analyzed 
whether the double knockout of HERC2 and p53 could 
also rescue the lethality. Our results show that the double 
knockout did not rescue the embryonic lethality, indicating 
a p53-independent role for HERC2 in development. 
Moreover, these data also confirm, at a genetic level, the 
different functions of MDM2 (or MDM4) and HERC2 in 
p53 regulation. 
HERC2 acts as an ubiquitin ligase tagging for 
degradation by the proteasome of substrates such as XPA, 
Figure 12: p62/sQstM1 in Herc2+/530 mice. Laser confocal microphotographs of coronal sections through the cerebellar cortex of 
the vermis of 9 months Herc2+/+ (wt, A) and 9 months old Herc2+/530 (+/530, B) mice double labeled with HERC2 and p62 antibodies. 
Colocalizations of HERC2 and p62 are indicated by arrows in dendrites and cell somata A., b., and by arrowheads in the axonal torpedoes 
of Herc2+/530 Purkinje cells (B). Asterisks in B indicate the absence of Purkinje cell bodies. Bar = 50 µm (A-B).
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BRCA1, NEURL4, FBXL5 or USP33 [21, 22, 24-26]. 
HERC2 may also positively regulate p53 activity through 
stimulation of its oligomerization [32]. The analysis 
of levels of USP33 and p21 led us to analyze these two 
activities, respectively. These activities had been reported 
in culture cell but not in physiological conditions. The 
generation of Herc2+/530 mice containing approximately 
one-half of the HERC2 protein (Figure 4) led us to 
analyze the role of HERC2 in vivo. Herc2+/530 mice had 
higher levels of USP33 protein and lower levels of p21 
mRNA (Figure 5). These results show for the first time the 
inhibition of HERC2 activity in physiological conditions. 
Individuals from the Amish community with a punctual 
mutation in HERC2, HERC2P594L, suffer a developmental 
disorder with features similar to Angelman syndrome 
[4,5]. These individuals produce an instable HERC2P594L 
protein. Skin fibroblasts obtained from these individuals 
also had higher levels of USP33 protein and lower levels 
of p21, in agreement with a loss of HERC2 activity. We 
showed how these results can be extrapolated to other 
human cells through interference RNA experiments. 
HERC2 knockdown caused an increase in the levels of 
USP33 protein and a decrease in the levels of p21. In 
conclusion, we show how the loss of HERC2 protein 
correlates with the loss of its activities, confirming the 
involvement of HERC2 in cellular processes regulated by 
USP33 [25] and p53 [32].
The tumor suppressor gene p53 is mutated in 
approximately 50% of human sporadic cancers and in 
inherited cancer predispositions, such as Li-Fraumeni 
syndrome [27, 28]. Homozygous p53-/- mice are highly 
prone to cancer, particularly T-cell lymphoma and 
sarcoma [36, 37]. Experiments with heterozygous 
p53+/- mice indicate that a mere reduction in p53 levels 
may be sufficient to promote tumorigenesis [38]. 
The p53 transcriptional activation is dependent of its 
oligomerization state [29], and p53 mutations that impair 
its oligomerization have been associated with the Li-
Fraumeni syndrome [30, 31]. Because HERC2 interacts 
with p53 and modulates its transcriptional activity by 
regulating its oligomerization [32] and Herc2+/530 mice 
have less p53 activity (Figure 5), we would expect 
Herc2+/530 mice to show an increased susceptibility to 
developing spontaneous tumors. However, we have 
not observed a greater number of tumors in Herc2530 
mice (data not shown). In agreement with these data, an 
increased susceptibility to develop spontaneous tumors 
in individuals from the Amish community with the 
HERC2P594L punctual mutation [4,5] and lower p53 activity 
(Figure 6) has not been reported. The hypothesis that 
loss of transcription in p53 is the driving force selected 
during tumorigenesis needs to be reevaluated, as it is 
far from straightforward. For example, mice expressing 
p53 mutants transcriptionally defective for growth arrest, 
senescence and apoptosis, are not prone to cancer [39,40]. 
Moreover, cells from mice deficient for the three p53 target 
genes, p21, Puma and Noxa, are deficient in their ability 
to undergo p53-mediated cell-cycle arrest, apoptosis, and 
senescence, although the animals remain tumor-free [41]. 
 Our study identifies a new function for the HERC2 
ubiquitin ligase as a regulator of motor coordination 
through regulation of Purkinje cells homeostasis. HERC2 
protein is expressed in Purkinje cells (Figure 9). The 
decrease of its protein levels correlates with the loss 
of Purkinje cells in the vermis and hemispheres of the 
cerebellum that would explain the motor incoordination 
detected in Herc2+/530 mice with rotarod experiments 
(Figures 7 and 8). The Purkinje cell loss is bilateral 
and symmetrical as in other mutations characterized 
by the Purkinje cells loss [42], demonstrating the 
specificity of the degenerative process. This loss is not 
homogeneously distributed; thus, the loss of Purkinje 
cells appears as discrete gaps in the continuous staining 
of the molecular layer of the vermis, while at the 
hemispheres, the loss reaches a great extension (Figure 
8). Despite their homogenous shapes and common 
morphological features, these results suggest some 
difference between Purkinje cells and is in agreement 
with previous observations indicating that these 
neurons do not constitute a biochemically homogenous 
population [42,43]. Pathological signs, such as varicose 
enlargements resembling axonal torpedoes and widespread 
accumulations of dense cytoplasmic material, were 
observed in Purkinje cells of Herc2+/530 mice. Proliferation 
of Golgi epithelial cells is also indicative of Purkinje cell 
degeneration. Electron microscopy analysis of Herc2+/530 
cerebella showed Purkinje cells containing numerous 
degenerating signs in autophagosomes, lysosomes 
and Golgi cisterns (Figure 10 and 11, and data not 
shown). These results resemble those obtained from 
a different mutant mouse called tambaleante [44,45]. 
In these animals, a progressive and specific loss of 
Purkinje cell was observed with a very similar pattern of 
neurodegenerative signs. Interestingly, the Purkinje cell 
degeneration in tambaleante mutant mice is a consequence 
of a missense mutation in HERC1 [44], the structural 
homolog of HERC2. In this regard, it seems that the 
functional alteration of one of them it is not compensated 
by the other. In agreement with this independent role of 
HERC1 and HERC2, the essential role of HERC1 for 
normal development and for neurotransmission at the 
mouse neuromuscular junction [46] was not observed in 
Herc2+/530 mice (Figure 7). Thus, both ubiquitin ligases 
seem to have a crucial and independent role in Purkinje 
cell physiology. This functional similarity of HERC1 
and HERC2 was unexpected, because despite their 
structural homology, endogenous proteins do not interact 
between them, do not have common known interactors, 
have different subcellular locations and were involved in 
different pathways of cell signaling [11, 12, 32]. However, 
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an interaction between the first 1,000 amino acid residues 
of HERC2 and HERC1 has recently been detected using 
mass spectrometry analysis [47], suggesting a possible 
interaction in some unknown circumstances. 
 A functional role of cerebellar p53 protein in 
adult walking synchronization has been reported [48]. 
Because HERC2 positively regulates p53 activity [32] and 
Herc2+/530 mice had less HERC2 activity, it was plausible 
that the impaired motor synchronization in Herc2+/530 mice 
was caused by a decrease in p53 activity. For this reason, 
we analyzed motor coordination in p53 knockout mice. 
We did not observe significant differences with rotarod 
experiments in these animals (Figure 7). Our results are 
in agreement with other studies where no differences in 
motor synchronization were detected by Tomasevic et 
al. [49] in p53 knockout mice. These authors described a 
role for p53 in the recovery of neuromotor function after a 
traumatic brain injury but not before the injury [49]. Thus, 
the motor coordination regulated by HERC2 seems to be 
independent of p53 activity.
 Pioneering studies associated mutations at the 
mouse Herc2 locus induced by ethylnitrosourea or 
ionizing radiation with a runty, jerky, sterile phenotype 
(rjs), also known as the juvenile development and 
fertility phenotype (jfd2), characterized by reduced size, 
jerky gait, fertility problems, including spermatocyte 
and oocyte abnormalities, defective maternal behaviour, 
and reduced lifespan with juvenile lethality [50-52]. 
More recently, a mutation in the HERC2 gene has been 
linked to the neurodevelopmental delay and dysfunction 
seen in Angelman syndrome and autism-spectrum 
disorders among the Amish community [4, 5]. Now, our 
study demonstrates an important role of HERC2 in the 
regulation of motor coordination through Purkinje cells 
homeostasis that would explain some features observed 
in rjs/jdf2 mice and individuals with the HERC2P594L 
mutation. It is important to note that, different to the above 
studies, the impaired motor synchronization is observed 
in mice with only a mutated allele of Herc2 (Herc2+/530 
mice), indicating the relevance of HERC2 activity in 
motor function coordination. 
 Studies of spontaneous mouse mutants have 
implicated autophagy in the death of Purkinje neurons. 
Lurcher mice with mutations in the delta2 glutamate 
receptor, pcd mice with loss of nna1 expression or 
tambaleante mice with mutation in the HERC1 protein 
show an increase of autophagy associated with Purkinje 
cell death [44, 53-55]. While conditional inactivation 
of autophagy genes such as Atg5 or Atg7 from Purkinje 
cells in mice yields Purkinje cell degeneration and death 
[56, 57]. This dual role of the autophagy in Purkinje cells 
degeneration seems to indicate that these neurons are very 
sensitive to the dysregulation of autophagy. Although 
more studies will be necessary to establish the role precise 
of HERC2 in autophagy, our results are in agreement with 
these previous observations in other mouse models, and 
reveal a dysregulation of autophagy in Herc2+/530 Purkinje 
cells. A recent study also suggests the involvement 
of HERC2 in Parkinson’s disease [58], it would be 
interesting to analyze in future studies the HERC2 role 
in the midbrain dopaminergic neurons of Herc2+/530 mice. 
 In summary, the generation of a mutant mouse of 
Herc2 led us to identify the HERC2 ubiquitin ligase as 
essential for embryonic development and an important 
regulator of motor coordination. These results may also 
explain some features observed among the Old Order 
Amish with a homozygous missense mutation in HERC2. 
Future studies will be necessary to identify additional 




The ES cell line AR0530 from The Sanger Institute 
containing a gene trap β-galactosidase/neomycin (β-geo-
Neo) cassette that has integrated between exons 2 and 
3 in the Herc2 gene was used. We choose this ES cell 
line to study Herc2 gene expression by β-galactosidase 
activity and to avoid the variability of the already existing 
Herc2 mutations (deletions, point mutations, DNA 
rearrangements) [50]. ES cells were injected into 4.5 day 
C57BL/6J blastocysts, which were then implanted into 
pseudopregnant females. The resulting 90-95% coat color 
chimeras were crossed with C57BL/6 mice to generate 
the heterozygous animals Herc2/Herc2530 (Herc2+/530). 
p53 knockout mice B6.129S2-Trp53tm1Tyj/J from Jackson 
laboratories [37] were kindly provided by Dr. J. Martin-
Caballero. All animal experiments were performed in 
accordance with guidelines approved by the Ethical 
Committee for Animal Experimentation of the University 
of Barcelona. 
Genotyping
Tail DNA or embryo samples were purified 
using the NucleoSpin Tissue kit (MACHEREY-
NAGEL) according to the manufacturer’s protocol. 
PCR amplification was performed using the primers: 
530KO1 5’GGCTGCCCAGTCTCGCCTTG3’ and 
530KO04 5’CTGTCACCTCTCCGGGAGAAC3’ 
for the amplification of the Herc2 wild-type allele; 
Gal7 5’TTTCCATATGGGGATTGGTG3’ and Gal8 
5’TGTCTGTTGTGCCCAGTCAT3’ for the Herc2 530 
allele; and p53036 5’ACAGCGTGGTGGTACCT3’ 
and p53037 5’TATACTCAGAGCCGGCCT p53038 5’ 
CTATCAAGGCATAGCGTTGG for the genotype of p53. 
The PCR settings were 94°C for 3 minutes, 94°C for 1 
minute, annealing at 60°C for 1 minute and elongation at 
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72°C for 1 minute, for 35 cycles. 
rt-Pcr
To assess trap expression, total RNA was isolated 
from mice tissues or cells using TRIsure reagent 
(Bioline). Two µg of total RNA was reverse-transcribed 
using the cDNA Reverse Transcription kit (Applied 
Biosystems) and random primers. To assess the trap 
insertion, PCR was carried out with primers: 530KO02 
5’CAGGTCTGACCACCCGGAGG3’; 530KO09 
5’GGGAGTTCTCGATTTTGTGC3’; and β-geo40/60 
5’AGGGTTTTCCCAGTCACGAC3’. The PCR settings 
were 94°C for 3 minutes, 94°C for 1 minute, annealing 
at 55°C for 30 seconds and elongation at 72°C for 45 
seconds, for 30 cycles. Additionally, cDNA was sequenced 
using BigDye 3.1 on an ABI 3130XL genetic analyzer 
(Applied Biosystems). To analyze the expression of p21, 
RT quantitative PCR was carried out using the ABI Prism 
7900 HT fast-real Time PCR system and commercially 
available Taqman assays (Applied Biosystems): CDKN1A 
(mouse p21: Mm04205640_g1; human p21: Hs00355783_
m1); GAPDH (mouse GAPDH: Mm99999915_g1; human 
GAPDH: Hs99999905_m1); and 18S (Hs99999901_s1). 
The PCR data were captured and analyzed using the 
Sequence Detector software (SDS version 2.3, Applied 
Biosystems). 
Histology and immunochemistry
X-gal staining of β-galactosidase activity. Mice were 
anesthetized and perfused via the left ventricle with 2% 
paraformaldehyde in a phosphate buffer (0.12 M). All 
tissues were dissected and fixed in the same solution for 3 
hours at 4ºC, and later were cryopreserved by immersion 
in 30% sucrose for 48 h at 4ºC. Whole tissues were then 
embedded into an 8% gelatin and 15% sucrose solution, 
frozen in liquid nitrogen and stored at -80ºC. Before 
staining for β-galactosidase activity, the tissues were 
sliced (7-10 μm), prepared on polylysinated slides, and 
permeabilized with PBS-0.3% Triton. After washing in 
PBS, the slices were incubated in staining solution (2 mM 
X-gal, 4 mM K4Fe(CN)6, 4 mM K3Fe(CN)6, 2 mM MgCl2 
in PBS) overnight while shaking in the dark at 4°C. After 
washing in PBS, the slices were stained with neutral red 
and mounted for microscopic observation.
The protocol to study the cerebellar Purkinje 
cells was reported previously [46]. Briefly, two and 
nine month old mice were deeply anaesthetised with 
pentobarbital (80 mg/kg i.p.), and perfused transcardially 
with 4% paraformaldehyde in 0.12 M phosphate buffer 
(PB, pH 7.2). After dissection, the brains were post-
fixed overnight in the same fixative and transferred to 
30% sucrose in PB until they sank. Sagittal and coronal 
sections of the cerebellum (40 µm thick) were cut on a 
freezing microtome, and collected in PBS. The sections 
were incubated overnight with a polyclonal anti-calbindin 
D-28k antibody (1:10,000). After washing, the sections 
were incubated for one hour in a biotinylated secondary 
antibody (1:500) followed by incubation for one hour in 
the ABC elite kit (1:400). A mixture of 0.3% DAB-0.6% 
nickel sulfate-0.1% hydrogen peroxide in PBS was used to 
reveal the immunoreaction. For double labeling analyses 
the sections were incubated overnight with the following 
primary antibodies mixtures: polyclonal anti-HERC2 
(1:400)/monoclonal anti-calbindin D-28k (1:1000), and 
polyclonal anti-HERC2 (1:400)/monoclonal anti-p62 
(1:100). After washing, the sections were incubated for 
one hour in a mixture of Alexa Fluor® 488 donkey-anti-
rabbit (1:500) and Alexa Fluor® 594 donkey-anti-mouse 
(1:500). Images were acquired in a Zeiss Axio-Imager M1 
microscope. Laser confocal analyses were made on an 
Olympus FluoView 1000 upright microscope. 
Electron microscopy
Two and nine month old mice were deeply 
anaesthetized with pentobarbital (80 mg/kg i.p.), 
and perfused transcardially with a mixture of 1% 
paraformaldehyde and 1% glutaraldehyde in 0,12 M 
phosphate buffer (PB, pH 7.2). Thereafter, the brains were 
dissected out and immersed overnight in the same fixative. 
Sagittal slices of the cerebella were cut and immersed in 
2% OsO4 in PB, stained in a block with ethanolic 0.5% 
uranyl acetate, dehydrated with an increased gradient of 
ethanol, and embedded in Durcupan (Fluka®). Semithin 
and ultrathin sections were obtained on a Leica EM UC7 
ultramicrotome. Semithin sections were stained with 
1% toluidine blue. Ultrathin sections were collected in 
copper grids (150 and 300 mesh) and observed without 
counterstaining in a Zeiss Libra EM at 80 kV (CITIUS).
behavioural tests
Anxiety
To evaluate mice anxiety, two different protocols 
were used [59]. Tail suspension: mice were suspended 
above the floor by fixing the end of the tail to wire netting 
and immobility was scored by manual observation during 
a 5 min test session. Time outside the dark box: mice were 
placed in a rectangular arena (55x40x40 cm3) with a dark 
box with a door. The time inside/outside the box was 




Mice were tested as described previously [60]. 
Briefly, mice were placed in a rectangular arena (55x40x40 
cm3) and two identical objects were placed in the arena 
during the training phase. Subsequently, the animal’s 
memory of one of the original objects was assessed by 
comparing the amount of time spent exploring the novel 
object as compared with that spent exploring the familiar 
one. The relative exploration of the novel object was 
expressed as a discrimination index [DI 5 (tnovel - tfamiliar)/
(tnovel + tfamiliar)]. 
step-through passive avoidance test
The test was performed as described previously 
[60]. Briefly, in the habituation phase, the mice were 
handled and allowed to move freely for 1 min in a 
chamber (47x18x26 cm3, manufactured by Ugo Basile). 
In the training phase, the mice were confined to the light 
compartment and then 30 s later, the door separating the 
dark-light compartments was opened. Once mice entered 
the dark compartment, the door closed automatically and 
the mice received an electrical stimulation (0.5 mA, 5 s) 
delivered through the metal floor. In the retention tests, the 
latency to enter into a dark compartment (escape latency) 
is a measure of information learning or memory retention. 
To compare the results obtained in different experiments, 
the fold change in escape latency with respect to the 
latency obtained in the training session is calculated.
Motor function
Motor activity in the open field
To evaluate locomotor and exploratory activity, mice 
were placed for 5 minutes in an open field (38×21×15 cm) 
(Cybertec S.A.). This apparatus consisted of a walled 
platform containing infrared emitters and sensors (IR) 
coupled to an altimeter, and the movement sensor was 
connected to a computer that recorded the number of times 
the mouse interrupted the IR beams/min.
Fore limb grip strength
To evaluate fore limb strength, mice were held 
above a horizontal wire and lowered to allow the fore 
limbs to grip the wire. The ability of the mice to remain 
attached by the fore limbs was scored during 10 s. 
rotarod
To habituate mice to the rotarod (Ugo Basile 
Biological Research Apparatus), the animals were placed 
on the roller at a speed of 20 rpm until they could remain 
on it for one minute without falling off. To assay motor 
coordination, animals were then tested at a rotational 
speed of 20 rpm, accelerating to 60 rpm in increments of 5 
rpm, and quantifying the number of falls at each increase 
in speed.
Electrophysiological analysis of the medial 
gastrocnemius (MG) muscle in mice
Compound muscular action potentials (CMAPs) 
were recorded in anesthetized mice (tribromethanol 2 %, 
0.15 ml/10 g body weight, i.p.) as described previously 
[46,61]. Briefly, the recording needle electrode was placed 
into the medial part of the MG muscle and the reference 
electrode was situated at the base of the fifth phalanx. 
A ground electrode was placed at the base of the tail. 
Stimulating needle electrodes were placed at the sciatic 
notch and the head of the fibula. Stimulation protocols of 
supramaximal current pulses (0.05 ms duration, 5-10 mA 
amplitude) were applied as a short train of 100 Hz pulses 
generated by an isolated pulse stimulator (Pulse Train 
Stimulator Cibertec cs-20). The outputs recorded were 
differentially amplified (P511 AC Amplifier Astro-Med, 
INC), digitally acquired at 10,000 samples/s (CED 1401 
Plus; Cambridge Electronic Designed, Cambridge, UK) 
and stored on a computer for later analysis. The analysis 
consisted of measuring the amplitude from the positive to 
the negative peak of the CMAPs recorded during a train 
of stimuli, normalizing the amplitude to the first response.
cell culture and transfection
Human fibroblasts and ethical statements were 
previously described [5]. U2OS cells were obtained 
from ATCC. Cells were cultured at 37°C in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum, 100 units/ml penicillin, 
100 µg/ml streptomycin and 2 mM glutamine. 
Transfection of cells with siRNAs (Non Targeting, 
NT: UAGCGACUAAACACAUCAA; HERC2, H2: 
GACUGUAGCCAGAUUGAAA) purchased from 
GenePharma was carried out using calcium phosphate. 
Transfected cells were analyzed 72 hours post-transfection. 
MG132 (Z-Leu-Leu-Leu-al) (Sigma-Aldrich) was added 
to the cells for 6 hours to a final concentration of 10 µM. 
Antibodies used
The following antibodies were used: anti-HERC2 
monoclonal (BD Biosciences); anti-HERC2 polyclonal 
[32]; anti-p21 (C-19); anti-p62 (SQSTM1 (D-3): sc-
28359); anti β-actin (Santa Cruz Biotechnology, Inc.); 
anti-calbindin D-28k polyclonal (Cb-38a, Swant); anti-
calbindin D-28k monoclonal (Cb-955, Sigma); anti-p53 
Oncotarget56103www.impactjournals.com/oncotarget
Ab-5 (DO-7) (Neo Markers); anti-USP33 (Proteintech); 
anti-Ran [62]; anti α-tubulin (Ab-1, Calbiochem); Alexa 
Fluor® 488 donkey-anti-rabbit (A21207), and Alexa 
Fluor® 594 donkey-anti-mouse (A21203) (Invitrogen); 
horseradish peroxidase-conjugated secondary antibodies 
(Invitrogen); biotin-conjugated secondary antibodies 
(Vector); and the Avidine-Streptavidine Elite Kit (Vector).
Lysate and immunoblot
Mice were euthanized by cervical dislocation. 
The organs were collected and frozen in liquid nitrogen 
and stored at -80°C until analysis. Tissues, human 
fibroblasts or U2OS cells were prepared in lysis buffer 
(consisting of 50 mM TrisHCl, pH 7.5, 150 mM NaCl, 
0.5% NP40, 50 mM β-glycerophosphate, 50 mM NaF, 
1 mM sodium vanadate, 1 mM phenyl-methylsulfonyl 
fluoride, 5 μg/mL leupeptin, 5 μg/mL aprotinin, 1 μg/
mL pepstatin-A and benzamidine 100 μg/mL) and the 
tissues were homogenized in a motor-driven Polytron 
PT3000. The lysates were incubated on ice for 20 minutes 
and centrifuged at 13,000 g for 10 minutes at 4°C. Total 
protein levels were measured by BCA (Pierce). Equal 
amounts of supernatant proteins were analyzed using the 
Tris-acetate PAGE system [63]. Band intensities were 
analyzed using a gel documentation system (LAS-3000, 
Fujifilm). Proteins levels were normalized and expressed 
as a percentage of controls. 
statistical analysis
The results are expressed as mean±SEM. The data 
were analyzed by one-way analysis of variance (ANOVA) 
or Student’s t-test. For comparison of significance, Tukey’s 
test was used as a post hoc test according to the statistical 
program GraphPad Prism. Differences were considered 
significant at p values of less than 0.05: *p < 0.05, **p < 
0.01, and ***p < 0.001.
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